Anteris Technologies Global Corp. (AVR)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Wayne Geoffrey Paterson
|
Vice Chairman & CEO | 1.67M | -- | 1967 |
|
Mr. David St. Denis
|
President & Director | 981.9k | -- | 1969 |
|
Mr. Matthew McDonnell
|
Head of Australia | 457.35k | -- | 1973 |
|
Mr. Brent A. Moen
|
Chief Financial Officer | -- | -- | 1967 |
|
Dr. Chris Meduri M.D., M.P.H.
|
Chief Medical Officer & Member of Medical Advisory Board | -- | -- | -- |
Anteris Technologies Global Corp.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 174
Description
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Corporate Governance
Upcoming Events
November 12, 2026 at 8:00 PM UTC
Anteris Technologies Global Corp. Earnings Date
